semaglutide in kidney disease Evolution of CKD risk after 12 months of treatment with Ozempic picks up FDA indication

Maintaining adequate hydration is paramount, particularly given semaglutide's gastrointestinal side effects

Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980-2017: a systematic analysis for the Global Burden of Disease Study 2017

Mechanism of Action: Semaglutide: It stimulates the GLP-1 receptors, leading to increased insulin secretion and reduced glucagon release, thereby lowering blood sugar levels

not a guarantee for any compounded product or any individual patient SURMOUNT-1 trial (NEJM): 20.9% average body weight loss with tirzepatide - same qualification

You would not judge semaglutide based on results at 0.25mg